We discount the pain of people we don’t like

According to a new study published in Pain

 

Philadelphia, PA, USA (October 3, 2011) – If a patient is not likeable, will he or she be taken less seriously when exhibiting or complaining about pain? Reporting in the October 2011 issue of Pain®, researchers have found that observers of patients estimate lower pain intensity and are perceptually less sympathetic to the patients’ pain when the patients are not liked.

 

40 study participants (17 men and 23 women) were preconditioned by viewing pictures of six different patients tagged with simple descriptions that ranged from negative (egoistic, hypocritical, or arrogant) to neutral (true to tradition, reserved, or conventional) to positive (faithful, honest, or friendly). After this preconditioning process, participants observed short videos of the patients undergoing a standardized physiotherapy assessment. The six patients observed were experiencing shoulder pain and eight short video fragments (2 seconds in duration) of each were selected, resulting in 48 different fragments. After each video fragment, the participants were asked to rate the severity of pain of the patients on a scale of "no pain" to "pain as bad as could be." Afterwards, the participants were also asked to judge the patients to be negative or positive, disagreeable or agreeable, and unsympathetic or sympathetic.

 

Investigators found that participants rated patients associated with negative traits as less likeable than patients associated with neutral traits. They rated patients associated with neutral traits as less likable than patients associated with positive traits. Further, pain of disliked patients expressing high intensity pain was estimated as less intense than pain of liked patients expressing high intensity pain. Furthermore, observers were less perceptually sensitive toward pain of negatively evaluated patients than to pain of positively evaluated patients, i.e. they were less able to discriminate between different levels of pain expressed by the disliked patients.

 

"Identifying variables that influence pain estimation by others is relevant as pain estimation might influence crucial actions concerning pain management both in the professional context as well as in the everyday environment," commented lead investigator Liesbet Goubert, PhD, assistant professor of Health Psychology and co-investigator Geert Crombez, PhD, head of the Department of Experimental-Clinical and Health Psychology, Ghent University, Belgium. "Our results suggest that pain of disliked patients who express high pain is taken less seriously by others. This could imply less helping behavior by others as well as poorer health outcomes."

 

 

The article is "When you dislike patients, pain is taken less seriously" by Lies De Ruddere, Liesbet Goubert, Ken Martin Prkachin, Michael André Louis Stevens, Dimitri Marcel Leon Van Ryckeghem, and Geert Crombez (DOI: 10.1016/j.pain.2011.06.028). It appears in Pain®, Volume 152, Issue 10 (October 2011) published by Elsevier.

 

 


Elsevier Health Sciences, 03.10.2011 (tB).

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung